An Open-Label Study of Lumateperone in Pediatric Subjects with Schizophrenia

  • Ages 13-17
  • Diagnosis or symptoms of schizophrenia without catatonia
  • Must be able to swallow a capsule and comply with all study procedures
  • Must maintain an outpatient status for the duration of the study
  • If you have history of medical issues such as seizures, blood disorders, or other major health conditions you may not qualify for this trial

Learn More About Participating in a Study

  • This field is for validation purposes and should be left unchanged.